• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 20 of 100
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
Health
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By Erin PraterOctober 2, 2023
CVS is promising to boost hiring after overworked pharmacists don’t show up, but longterm solution to worker shortage is elusive
Success
CVS is promising to boost hiring after overworked pharmacists don’t show up, but longterm solution to worker shortage is elusive
By Josh Funk and The Associated PressSeptember 28, 2023
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
Commentary
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
By Howard DeanSeptember 19, 2023
a box of wegovy medication
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By Prarthana PrakashSeptember 5, 2023
Smoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
Commentary
Smoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
By Jeffrey SonnenfeldAugust 31, 2023
U.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
Commentary
U.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
By John G. SingerAugust 10, 2023
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
Health
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By Erin PraterAugust 8, 2023
Diabetes drug Ozempic
Magazine
Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By Vivienne WaltJuly 31, 2023
Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
Health
Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
By Erin PraterJuly 21, 2023
Digitalization could be the answer to better health care for patients. But first, they need to trust it
Newsletters
Digitalization could be the answer to better health care for patients. But first, they need to trust it
By Eamon BarrettJuly 21, 2023
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
Health
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
By Riley Griffin and BloombergJuly 19, 2023
NYSE trader
Finance
The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By Angel Adegbesan and BloombergJuly 12, 2023
woman at mirror
Health
Ozempic isn’t alone. A whole class of ‘revolutionary’ weight-loss drugs is on the market—but only for the wealthy
By Rachel ShinJuly 9, 2023
Eli Lilly’s CEO pinpoints the 3-prong problem big execs face with remote work
Success
Eli Lilly’s CEO pinpoints the 3-prong problem big execs face with remote work
By Jane ThierJune 24, 2023
Ozempic is pictured in a pharmacy on April 13, 2023 in Niesky, Germany.
Features
The maker of Ozempic and Wegovy is researching groundbreaking new drugs to stop people from becoming obese in the first place
By Vivienne WaltJune 21, 2023
1...
  • 18
  • 19
  • 20
  • 21
  • 22
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.